Cargando…
Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers
The clinical spectrum of the anti-phospholipid syndrome (APS) is not limited to vascular thrombosis or miscarriages but includes additional manifestations that cannot be explained solely by a thrombophilic state. Anti-cardiolipin, anti-beta(2) glycoprotein I (anti-β(2)GPI) and lupus anticoagulant (L...
Autores principales: | Meroni, Pier Luigi, Chighizola, Cecilia Beatrice, Rovelli, Francesca, Gerosa, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060447/ https://www.ncbi.nlm.nih.gov/pubmed/25166960 http://dx.doi.org/10.1186/ar4549 |
Ejemplares similares
-
Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications
por: Tedesco, Francesco, et al.
Publicado: (2018) -
Treatment of Thrombotic Antiphospholipid Syndrome: The Rationale of Current Management—An Insight into Future Approaches
por: Chighizola, Cecilia Beatrice, et al.
Publicado: (2015) -
Pediatric Antiphospholipid Syndrome: from Pathogenesis to Clinical Management
por: Rosina, Silvia, et al.
Publicado: (2021) -
Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies
por: Lazzaroni, Maria-Grazia, et al.
Publicado: (2019) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)